EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Antihypertensive activity of the non-peptide angiotensin II receptor antagonist, SK&F 108566, in rats and dogs






Naunyn-Schmiedeberg's Archives of Pharmacology 345(6): 673-678

Antihypertensive activity of the non-peptide angiotensin II receptor antagonist, SK&F 108566, in rats and dogs

The antihypertensive activity of the nonpeptide angiotensin II receptor antagonist, SK&F 108566 (E)-alpha-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5- yl]methylene]-2-thiophene propanoic acid), was examined in rats and dogs. SK&F 108566 produced dose-dependent decreases in blood pressure in renin-dependent hypertensive rats. At 10 mg/kg intraduodenally, mean arterial blood pressure fell from between 150-160 mm Hg to approximately 124 mm Hg. A sustained infusion of SK&F 108566 at 25 micrograms/min intraduodenally normalized blood pressure during 3 days of infusion and for 18 h following cessation of the infusion. Evaluation of the systemic hemodynamic effects of SK&F 108566 in chronically instrumented renin-dependent hypertensive rats demonstrated that the antihypertensive effects of SK&F 108566 were accompanied by a significant increase in cardiac output with little change in stroke volume. In dogs made acutely hypertensive by an intravenous infusion of angiotensin I, SK&F 108566 resulted in dose-dependent decreases in blood pressure. The antihypertensive activity of SK&F 108566 at 10 mg/kg p.o. was maintained for between 13-15 h, a similar duration of action as observed with enalapril (1 mg/kg, p.o.). Administration of DuP 753 (losartan) intravenously caused a small and short-lived fall in blood pressure in the angiotensin I-infused hypertensive dog. However, the active metabolite of losartan, EXP 3174, resulted in a response of longer duration. In dogs made hypertensive by placement of an ameroid constrictor on the left renal artery, SK&F 108566 (10 mg/kg, p.o.) or enalapril (1 mg/kg, p.o.) resulted in antihypertensive responses of at least 12 h duration. The data indicate that SK&F 108566 is a long-acting antihypertensive agent in the rat and dog.

(PDF 0-2 workdays service: $29.90)

Accession: 039300431

PMID: 1635591



Related references

Antihypertensive activity of the non peptide angiotensin ii receptor antagonist skf 108566 in rats and dogs. Naunyn-Schmiedeberg's Archives of Pharmacology 345(6): 673-678, 1992

Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogs. European Journal Of Pharmacology. 335(2-3): 175-184, 1997

The pharmacokinetics and metabolism of DuP 532, a non-peptide angiotensin II receptor antagonist, in rats and dogs. Biopharmaceutics & Drug Disposition 15(1): 53-63, 1994

Does a relationship exist between the antihypertensive action and the angiotensin receptor antagonist activity of dup 753 in conscious rats?. British Journal of Pharmacology 104(PROC SUPPL OCT): 126P, 1991

Pharmacological characterization of the nonpeptide angiotensin ii receptor antagonist sk and f 108566. Journal of Pharmacology & Experimental Therapeutics 260(1): 175-181, 1992

Renal hemodynamic effects of SK and F 108566, a nonpeptide selective angiotensin receptor AT1 antagonist. Clinical Pharmacology & Therapeutics 55(2): 206, 1994

The angiotensin II receptor antagonist SKF 108566 does not increase uric acid excretion in healthy men. Journal of the American Society of Nephrology 4(3): 530, 1993

Antihypertensive profiles of GA0056, a novel non-peptide angiotensin II receptor antagonist. Japanese Journal of Pharmacology 64(SUPPL 1): 336P, 1994

Antihypertensive and renal hemodynamic effects of a novel non-peptide angiotensin II receptor antagonist. Japanese Journal of Pharmacology 61(SUPPL 1): 169P, 1993

Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody. Journal of Pharmacology and Experimental Therapeutics 250(2): 515-522, 1989